View More
Download this focused resource for a quick guide to EGFR-targeted agents used in current practice for patients with advanced NSCLC and EGFR mutations, including exon 20 insertions.
Download this clinical resource for expert recommendations from May 2022 on molecular testing for targetable genetic alterations in patients with advanced NSCLC.
Download this short resource for a summary of ongoing clinical trials and active areas of research in the setting of EGFR-mutated NSCLC.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.